Pharma Mar 過去の業績
過去 基準チェック /16
Pharma Marの収益は年間平均-24.8%の割合で減少していますが、 Biotechs業界の収益は年間 増加しています。収益は年間7.7% 1.3%割合で 減少しています。 Pharma Marの自己資本利益率は0.3%であり、純利益率は0.4%です。
主要情報
-24.8%
収益成長率
-35.5%
EPS成長率
| Biotechs 業界の成長 | -7.2% |
| 収益成長率 | -1.3% |
| 株主資本利益率 | 0.3% |
| ネット・マージン | 0.4% |
| 前回の決算情報 | 30 Sep 2024 |
最近の業績更新
Recent updates
Pharma Mar, S.A.'s (BME:PHM) Price Is Right But Growth Is Lacking After Shares Rocket 55%
Oct 16
Pharma Mar, S.A.'s (BME:PHM) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Jul 28Pharma Mar (BME:PHM) Will Pay A Larger Dividend Than Last Year At €0.65
Jun 01Pharma Mar, S.A.'s (BME:PHM) Shares Bounce 29% But Its Business Still Trails The Industry
May 28Pharma Mar, S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 03Here's Why Pharma Mar (BME:PHM) Has A Meaningful Debt Burden
Jan 25Pharma Mar, S.A. (BME:PHM) Shares Could Be 30% Below Their Intrinsic Value Estimate
Apr 28We Believe That Pharma Mar's (BME:PHM) Weak Earnings Are A Good Indicator Of Underlying Profitability
Mar 08Analyst Forecasts Just Became More Bearish On Pharma Mar, S.A. (BME:PHM)
Mar 05Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
Feb 09We Think Pharma Mar (BME:PHM) Can Manage Its Debt With Ease
Oct 27An Intrinsic Calculation For Pharma Mar, S.A. (BME:PHM) Suggests It's 21% Undervalued
Sep 27Does Pharma Mar (BME:PHM) Have A Healthy Balance Sheet?
Jul 15Growth Investors: Industry Analysts Just Upgraded Their Pharma Mar, S.A. (BME:PHM) Revenue Forecasts By 24%
May 04Pharma Mar (BME:PHM) Has A Pretty Healthy Balance Sheet
Apr 11There Is A Reason Pharma Mar, S.A.'s (BME:PHM) Price Is Undemanding
Mar 16Is Pharma Mar (BME:PHM) Using Too Much Debt?
Jan 09Pharma Mar (BME:PHM) Seems To Use Debt Quite Sensibly
Sep 08News Flash: Analysts Just Made A Meaningful Upgrade To Their Pharma Mar, S.A. (BME:PHM) Forecasts
Aug 03Here's Why I Think Pharma Mar (BME:PHM) Is An Interesting Stock
May 31Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
May 10Is Pharma Mar, S.A. (BME:PHM) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 08Announcing: Pharma Mar (BME:PHM) Stock Increased An Energizing 231% In The Last Five Years
Jan 14Is Pharma Mar (BME:PHM) A Risky Investment?
Nov 19収支内訳
収支内訳
Pharma Mar の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Sep 24 | 167 | 1 | 45 | 105 |
| 30 Jun 24 | 159 | -2 | 44 | 104 |
| 31 Mar 24 | 162 | 2 | 43 | 105 |
| 31 Dec 23 | 158 | 1 | 42 | 99 |
| 30 Sep 23 | 168 | 14 | 40 | 95 |
| 30 Jun 23 | 175 | 21 | 43 | 90 |
| 31 Mar 23 | 177 | 29 | 42 | 85 |
| 31 Dec 22 | 196 | 49 | 43 | 83 |
| 30 Sep 22 | 235 | 79 | 48 | 85 |
| 30 Jun 22 | 233 | 85 | 42 | 84 |
| 31 Mar 22 | 232 | 91 | 41 | 76 |
| 31 Dec 21 | 230 | 93 | 40 | 72 |
| 30 Sep 21 | 188 | 63 | 34 | 61 |
| 30 Jun 21 | 200 | 67 | 35 | 58 |
| 31 Mar 21 | 222 | 91 | 35 | 56 |
| 31 Dec 20 | 270 | 137 | 36 | 54 |
| 30 Sep 20 | 246 | 147 | 37 | 48 |
| 30 Jun 20 | 214 | 124 | 38 | 47 |
| 31 Mar 20 | 166 | 72 | 39 | 48 |
| 31 Dec 19 | 86 | -9 | 38 | 51 |
| 30 Sep 19 | 136 | -27 | 58 | 58 |
| 30 Jun 19 | 84 | -37 | 38 | 61 |
| 31 Mar 19 | 154 | -24 | 59 | 69 |
| 31 Dec 18 | 109 | -17 | 39 | 74 |
| 30 Sep 18 | 189 | -16 | 66 | 80 |
| 30 Jun 18 | 128 | -20 | 44 | 119 |
| 31 Mar 18 | 179 | -26 | 65 | 79 |
| 31 Dec 17 | 159 | -28 | 58 | 79 |
| 30 Sep 17 | 182 | -22 | 67 | 77 |
| 30 Jun 17 | 186 | -18 | 74 | 78 |
| 31 Mar 17 | 184 | -19 | 67 | 78 |
| 31 Dec 16 | 181 | -24 | 68 | 78 |
| 30 Sep 16 | 187 | -18 | 68 | 75 |
| 30 Jun 16 | 188 | -10 | 71 | 60 |
| 31 Mar 16 | 190 | -7 | 70 | 66 |
| 31 Dec 15 | 194 | 7 | 69 | 60 |
| 31 Dec 14 | 175 | 13 | 60 | 46 |
| 31 Dec 13 | 74 | 12 | 59 | 0 |
質の高い収益: PHM 非現金収入 のレベルが高いです。
利益率の向上: PHMの現在の純利益率 (0.4%)は、昨年(8.3%)よりも低くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: PHM過去 5 年間で収益を上げており、収益は年間-24.8%増加しています。
成長の加速: PHMは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。
収益対業界: PHMは過去 1 年間で収益成長率がマイナス ( -95.5% ) となったため、 Biotechs業界平均 ( -18.2% ) と比較することが困難です。
株主資本利益率
高いROE: PHMの 自己資本利益率 ( 0.3% ) は 低い とみなされます。